ANXA10 and CD24 positive rates as well as the co-expression rate in normal pancreas, cancer adjacent normal pancreas tissues, chronic pancreatitis, PanINs, IPMNs, and PDACs, respectively. This evidence concerns the gene CD24 and cancer.